MPH Mittelstndische Pharma Holding AG: Preliminary IFRS results 2014, sales of EUR 219.24 million, net income of EUR …

In the financial year 2014 the preliminary IFRS Group sales amounted toapproximately EUR 219.24 million (previous year: EUR 226.84 million) andthe preliminary IFRS consolidated net income was about EUR 8.46 million(previous year: EUR 7.49 million). The preliminary earnings per sharereached EUR 0.19 (previous year: EUR 0.18).The substance has been further strengthened. The preliminary IFRS equityincreased to EUR 94.73 million (previous year: EUR 79.19 million). Theliquidity position improved to EUR 10.12 million (previous year: EUR 5.85million).The business strategy of "making a contribution towards maintaininghealthcare affordable" has paid off. In the healthcare market MPH AG isfollowing this strategy with an attractive offer of medicines and medicalservices with focus on oncology and HIV in the health insurance reimbursedmarket and with focus on aesthetic medicine in the self-pay market.About MPH Mittelstndische Pharma Holding AG:The company MPH Mittelstndische Pharma Holding AG, based in Berlin, hasstrategically concentrated its activities on the growth segments Pharma andHealthcare. The pharmaceutical sector makes a contribution towards cuttingcosts in the healthcare system with medicines manufactured on the basis ofpatent-free and patent-protected active substances for the therapy ofchronic diseases. The field of healthcare offers healthcare preparations,individual patient therapies, aesthetic surgeries and other medicaltreatments.Key figures for the share of MPH Mittelstndische Pharma Holding AG:Subscribed capital: EUR 42,813,842Listed shares: ordinary sharesISIN: DE000A0L1H32WKN: A0L1H3Stock symbol: 93MContact: Linda ReicheltMPH Mittelstndische Pharma Holding AGFasanenstrae 77D-10623 BerlinPhone:+49 (0)30 897308660 Fax:+49 (0)30 897308669E-Mail: ir@mph-ag.de Web: http://www.mph-ag.de---------------------------------16.03.2015 Dissemination of a Corporate News, transmitted by DGAP - aservice of EQS Group AG.The issuer is solely responsible for the content of this announcement.The DGAP Distribution Services include Regulatory Announcements,Financial/Corporate News and Press Releases.Media archive at http://www.dgap-medientreff.de and http://www.dgap.de---------------------------------Language: English Company: MPH Mittelstndische Pharma Holding AG Fasanenstrae 77 10623 Berlin Germany Phone: 030 / 897 308 660 Fax: 030 / 897 308 669 E-mail: info@mph-ag.de Internet: http://www.mph-ag.de ISIN: DE000A0L1H32 WKN: A0L1H3 Listed: Regulated Unofficial Market in Berlin, Dusseldorf, Stuttgart; Open Market (Entry Standard) in Frankfurt End of News DGAP News-Service --------------------------------- 333387 16.03.2015

MPH Mittelstndische Pharma Holding

Aktuelle Diskussionen zum Thema:

MPH dominierender Anteilseigner ... (16.03.15) MPH Zahlen Geschftsbericht ... (06.08.14) MPH - Haemato - Super Zahlen!! (16.10.13)

Aktuelle Nachrichten zum Unternehmen:

DGAP-News: MPH Mittelstndische. (16.03.15) First Berlin - MPH Mittelstaendisch. (01.09.14) MPH-Aktie: Positive Entwicklung in. (04.06.14) MPH-Aktie: Anstieg bei Umsatzerl. (22.05.14) MPH-Aktie: Hohe stille Reserven u. (21.05.14)

Alle Nachrichten zum Unternehmen

Aktuelle Analysen zu den Unternehmen:

MPH Mittelstndische Pharma Holding

Read the original here:
MPH Mittelstndische Pharma Holding AG: Preliminary IFRS results 2014, sales of EUR 219.24 million, net income of EUR ...